Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)LeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - Other
Ratios

Amylyx Pharmaceuticals (AMLX) Receivables - Other (2022 - 2025)

Amylyx Pharmaceuticals has reported Receivables - Other over the past 4 years, most recently at $100000.0 for Q4 2025.

  • Quarterly results put Receivables - Other at $100000.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $100000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $100000.0, changed 0.0%.
  • Receivables - Other for Q4 2025 was $100000.0 at Amylyx Pharmaceuticals, roughly flat from $100000.0 in the prior quarter.
  • Over the last five years, Receivables - Other for AMLX hit a ceiling of $800000.0 in Q2 2023 and a floor of $100000.0 in Q3 2023.
  • Median Receivables - Other over the past 4 years was $100000.0 (2023), compared with a mean of $246153.8.
  • Biggest five-year swings in Receivables - Other: changed 0.0% in 2023 and later tumbled 87.5% in 2024.
  • Amylyx Pharmaceuticals' Receivables - Other stood at $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023, then crashed by 80.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
  • The last three reported values for Receivables - Other were $100000.0 (Q4 2025), $100000.0 (Q3 2025), and $100000.0 (Q2 2025) per Business Quant data.